The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression
Abstract
The etiology of mood disorders is mechanistically heterogeneous, underscoring the need for a dimensional approach to identify and develop targeted treatments in psychiatry. Accumulating evidence implicates inflammation as an important contributor to the pathophysiology of depression and presents the immune system as a viable therapeutic target that may be more proximate to the pathogenic nexus of brain-based disorders in specific subpopulations. Anhedonia is a transdiagnostic (e.g. Parkinson’s disease, diabetes mellitus, rheumatic diseases), yet specific, and clinically relevant symptom dimension subserved by well-characterized neurobiological and neurophysiological substrates of the positive valence systems (PVS). Brain circuits, nodes, and networks, as well as cellular and molecular pathways (e.g. dopaminergic transmission; excitotoxicity; synaptic plasticity), subserving anhedonia are preferentially affected by inflammatory processes. To our knowledge, no published randomized, controlled clinical trial in populations with mood disorders has, to date, primarily sought to determine the effects of an anti-inflammatory agent on PVS functions or pathophysiology. Three ongoing clinical trials aim to investigate the effects of anti-TNF-alpha biologic infliximab on measures of anhedonia [ClinicalTrials.gov identifier: NCT02363738], motivational behavior and circuitry [ClinicalTrials.gov identifier: NCT03006393], and glutamatergic changes in the basal ganglia [ClinicalTrials.gov identifier: NCT03004443] in clinical populations with unipolar or bipolar depression. Positive results would further instantiate the relevance of inflammatory processes and the immune system in the pathophysiology of mood disorders and provide the impetus to develop scalable treatments targeting inflammation and the immune system to mitigate transdiagnostic, dimensional disturbances in brain-based disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is separately reported that disparate antidepressant modalities influence peripheral cytokine concentrations in adults with depression (6).”
From The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis (2022) · cites this paper as [6]
In the citing paper
“It is also reported that an activated inflammatory system is associated with abnormal hedonic and cognitive function in adults with depression (5–7).”
From The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis (2022) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Toward the future of psychiatric diagnosis: the seven pillars of RDoC
Cuthbert, B. N., & Insel, T. R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-126 · Cited by 3,053
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
Drysdale, A. T., Grosenick, L., Downar, J., Dunlop, K., Mansouri, F., Meng, Y., Fetcho, R. N., Zebley, B., Oathes, D. J., Etkin, A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4246 · Cited by 2,170
The brain reward circuitry in mood disorders
Russo, S. J., & Nestler, E. J. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3381 · Cited by 1,870
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Research works printed but not linked: 58
- 10.1176/appi.ajp.157.6.867 · DOI · Paper page
- 10.1016/j.jpsychores.2014.07.020 · DOI
- 10.1016/j.neuroimage.2012.06.055 · DOI · Paper page
- 10.1016/0006-8993(92)91588-6 · DOI · Paper page
- 10.1006/brbi.2000.0613 · DOI · Paper page
- 10.1155/2016/9085273 · DOI
- 10.1176/appi.psy.44.2.104 · DOI · Paper page
- 10.4088/JCP.v66n0814 · DOI
- 10.1176/jnp.16.2.185 · DOI
- 10.1016/S0165-0327(02)00264-1 · DOI · Paper page
- 10.1016/j.bbi.2015.12.005 · DOI
- 10.1007/s10067-010-1651-8 · DOI
- 10.1111/j.1756-185X.2010.01591.x · DOI
- 10.1016/j.neubiorev.2014.12.017 · DOI · Paper page
- 10.1097/JCP.0b013e3181bef8a6 · DOI
- 10.1111/bdi.12166 · DOI
- 10.4088/JCP.08r04505 · DOI · Paper page
- Marrie RA, 2017, Epidemiol Psychiatr Sci, 1
- 10.1017/S0033291708003188 · DOI · Paper page
- Ho RC, 2010, Ann Acad Med Singapore, 39, 191, 10.47102/annals-acadmedsg.V39N3p191 · DOI
- 10.1038/nm.3893 · DOI · Paper page
- 10.1016/j.biopsych.2013.01.007 · DOI · Paper page
- 10.1016/j.biopsych.2009.09.033 · DOI · Paper page
- 10.1002/brb3.200 · DOI
- 10.1192/apt.bp.113.011619 · DOI
- 10.1038/srep35239 · DOI
- 10.1016/j.jpsychires.2015.12.003 · DOI
- 10.1523/JNEUROSCI.1671-13.2013 · DOI · Paper page
- 10.1001/jamapsychiatry.2014.2427 · DOI · Paper page
- 10.1016/j.biopsych.2009.11.005 · DOI · Paper page
- 10.1016/j.bbi.2011.10.010 · DOI · Paper page
- 10.3899/jrheum.150884 · DOI
- 10.1176/appi.ajp.2010.09091379 · DOI · Paper page
- 10.1176/appi.books.9780890425596 · DOI · Paper page
- 10.1016/j.schres.2014.10.028 · DOI
- 10.1097/NMD.0b013e3182349ce6 · DOI
- Rømer Thomsen K, 2015, Front Behav Neurosci, 9, 49
- 10.1097/YCO.0000000000000122 · DOI · Paper page
- 10.1016/j.psyneuen.2016.04.002 · DOI
- 10.1192/bjp.bp.114.154781 · DOI
- 10.1001/archgenpsychiatry.2010.36 · DOI
- 10.1016/j.clineuro.2013.10.013 · DOI
- 10.1016/j.jns.2006.05.024 · DOI
- 10.1176/appi.neuropsych.11110332 · DOI
- 10.1017/S0033291707001730 · DOI · Paper page
- Haber SN., 2012, Neurobiology of sensation and reward
- 10.1002/hbm.21268 · DOI · Paper page
- 10.1016/j.jad.2016.09.056 · DOI · Paper page
- 10.1007/s00702-014-1187-1 · DOI
- 10.1038/npp.2016.143 · DOI · Paper page
- 10.1038/npp.2016.191 · DOI
- 10.1016/j.biopsych.2009.03.015 · DOI · Paper page
- 10.1176/appi.ajp.2016.16070774 · DOI · Paper page
- 10.4088/JCP.16m11310 · DOI
- 10.4088/JCP.14m09587 · DOI
- 10.1038/mp.2015.22 · DOI · Paper page
- Schmidt FM, 2014, Psychiatr Danub, 26, 288
- 10.1016/j.pharmthera.2007.10.001 · DOI · Paper page
Cited by
Hao, F., Tan, W., Jiang, L., Zhang, L., Zhao, X., Zou, Y., Hu, Y., Luo, X., Jiang, X., McIntyre, R. S., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.069 · Cited by 968
Self-citationAlvarez-Mon, M. A., Gómez-Lahoz, A. M., Orozco, A., Lahera, G., Diaz, D., Ortega, M. A., Albillos, A., Quintero, J., Aubá, E., Monserrat, J., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030220 · Cited by 57
Ma, H., Xu, J., Li, R., McIntyre, R. S., Teopiz, K. M., Cao, B., & Yang, F. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.844176 · Cited by 22
Self-citation
Metadata
- Authors
- Lee, Y., Subramaniapillai, M., Brietzke, E., Mansur, R. B., Ho, R. C., Yim, S. J., & McIntyre, R. S.
- Affiliations
- Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada
- Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada
- Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
- Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Department of Psychiatry, University of Toronto, Toronto, ON, Canada
- Department of Psychological Medicine, National University of Singapore, Singapore
- Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada
- Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada Department of Psychiatry, University of Toronto, Toronto, ON, Canada Department of Pharmacology, University of Toronto, Toronto, ON, Canada
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2018-11-19
- Volume
- 8
- Issue
- 12
- Pages
- 337-348
- ISSN
- 2045-1253
- 2045-1261
- Cited by
- 62
- References
- 51
- Language
- en
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression. https://app.cochat.ai/papers/10.1177/2045125318791944
- The paper
- Lee, Y., Subramaniapillai, M., Brietzke, E., Mansur, R. B., Ho, R. C., Yim, S. J., & McIntyre, R. S. (2018). Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125318791944
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.